Search

everythinglearnresearchcommunity

for

Search:↓

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

Some alopecia treatments might help treat COVID-19, but more research is needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Phyllanthus emblica leaves show potential for developing new antimalarial drugs with low toxicity.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

Using existing drugs for new treatments is cost-effective and safer.

Cepharanthine is safe but not effective in significantly reducing COVID-19 recovery time.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

The letter is skeptical about the effectiveness of anti-androgen therapy for COVID-19 and calls for strong evidence from clinical trials.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Recreational drug use can cause misdiagnosed conditions and drug interactions in HIV patients.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

Adiantum capillus-veneris may help with respiratory issues, but more research is needed.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

Reinfection patients had more physical complications, while initial infection patients had more mental health issues.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

More research is needed to understand sex and racial differences in long COVID.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

AI can effectively predict COVID-19 mortality risk using patient data.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

The pandemic caused new skin problems in children, mainly due to mask-wearing and stress.

Many recovered COVID-19 patients, especially women, experience lingering symptoms like fatigue and headaches.